Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study

Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall association with chronic inflammation and poo...

Full description

Bibliographic Details
Main Authors: Salim S. Hayek, Yi-An Ko, Mosaab Awad, Hina Ahmed, Brandon Gray, Kareem Mohammed Hosny, Hiroshi Aida, Melissa J. Tracy, Changli Wei, Sanja Sever, Jochen Reiser, Arshed A. Quyyumi
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:Kidney International Reports
Subjects:
CKD
CRP
FDP
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917300189